InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Monday, 07/27/2020 9:16:42 PM

Monday, July 27, 2020 9:16:42 PM

Post# of 233220
Where is our big talking CEO


National Institutes of Health Selects Humanigen’s Lenzilumab for its COVID-19 Big Effect Trial. Big Effect Trial (BET) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) to advance high priority therapeutic candidates for COVID-19
Lenzilumab will be evaluated in combination with remdesivir and compared to placebo and remdesivir
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News